These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16408072)

  • 1. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
    Sakamoto H; Okamoto K; Aoki M; Kato H; Katsume A; Ohta A; Tsukuda T; Shimma N; Aoki Y; Arisawa M; Kohara M; Sudoh M
    Nat Chem Biol; 2005 Nov; 1(6):333-7. PubMed ID: 16408072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts.
    Aizaki H; Lee KJ; Sung VM; Ishiko H; Lai MM
    Virology; 2004 Jul; 324(2):450-61. PubMed ID: 15207630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
    Njoroge FG; Chen KX; Shih NY; Piwinski JJ
    Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
    Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
    Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
    Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
    J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network based analysis of hepatitis C virus core and NS4B protein interactions.
    Tripathi LP; Kataoka C; Taguwa S; Moriishi K; Mori Y; Matsuura Y; Mizuguchi K
    Mol Biosyst; 2010 Dec; 6(12):2539-53. PubMed ID: 20953506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity.
    Trujillo-Murillo K; Alvarez-Martínez O; Garza-Rodríguez L; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña H; Rincón-Sánchez AR; Rivas-Estilla AM
    J Viral Hepat; 2007 Sep; 14(9):608-17. PubMed ID: 17697012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
    Watashi K; Shimotohno K
    Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation systems for anti-HCV drugs.
    Moriishi K; Matsuura Y
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of lipid rafts in hepatitis C virus life cycle].
    Grek M; Bartkowiak J; Sidorkiewicz M
    Postepy Biochem; 2007; 53(4):334-43. PubMed ID: 19024898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis.
    Aizaki H; Choi KS; Liu M; Li YJ; Lai MM
    J Biomed Sci; 2006 Jul; 13(4):469-80. PubMed ID: 16691359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host cell responses induced by hepatitis C virus binding.
    Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
    Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
    Cristina J; del Pilar Moreno M; Moratorio G
    Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host factors involved in the replication of hepatitis C virus.
    Moriishi K; Matsuura Y
    Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Suppression of hepatitis C virus with the reagent targetting host factors].
    Hirata Y; Sudoh M; Kohara M
    Uirusu; 2008 Dec; 58(2):207-13. PubMed ID: 19374199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boceprevir, an NS3 protease inhibitor of HCV.
    Berman K; Kwo PY
    Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
    Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
    Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Induces the Localization of Lipid Rafts to Autophagosomes for Its RNA Replication.
    Kim JY; Wang L; Lee J; Ou JJ
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28747506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.